Chen et al. (52) observed that the ATF6 signaling pathway is one of the keys which affects the progression of NAFLD via regulating the ERS-induced inflammation and apoptosis. This evidence concerns the gene ATF6 and metabolic dysfunction-associated steatotic liver disease.